Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
about
What Is the Best Definitive Treatment for Graves’ Disease? A Systematic Review of the Existing LiteratureRituximab for thyroid-associated ophthalmopathyRituximab for thyroid-associated ophthalmopathyRecent developments in thyroid eye diseaseDrug discovery in ophthalmology: past success, present challenges, and future opportunitiesCurrent concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal studyGraves' ophthalmopathyNuclear targeting of IGF-1 receptor in orbital fibroblasts from Graves' disease: apparent role of ADAM17An altered phenotype in a conditional knockout of Pitx2 in extraocular muscle.Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy.Increased retinal blood flow in patients with active Graves' ophthalmopathy.Update on the medical treatment of Graves' ophthalmopathyImmunopathogenesis of thyroid eye disease: emerging paradigmsHypoxia increases adipogenesis and affects adipocytokine production in orbital fibroblasts-a possible explanation of the link between smoking and Graves' ophthalmopathy.Evidence for enhanced Thy-1 (CD90) expression in orbital fibroblasts of patients with Graves' ophthalmopathy.Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surfaceDiosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.Perimysial fibroblasts of extraocular muscle, as unique as the muscle fibersInsulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?Markers of inflammation and fibrosis in the orbital fat/connective tissue of patients with Graves' orbitopathy: clinical implicationsDecrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.Interleukin-27 and interferon-gamma are involved in regulation of autoimmune arthritisThyrotropin receptor and CD40 mediate interleukin-8 expression in fibrocytes: implications for thyroid-associated ophthalmopathy (an American Ophthalmological Society thesis)Increased Toll-Like Receptors Activity and TLR Ligands in Patients with Autoimmune Thyroid Diseases.Disturbances of modulating molecules (FOXP3, CTLA-4/CD28/B7, and CD40/CD40L) mRNA expressions in the orbital tissue from patients with severe graves' ophthalmopathyA difficult diagnosis: severe Graves' ophthalmolopathy.Graves' ophthalmopathy as an indication increased the risk of hypoparathyroidism after bilateral thyroidectomyActivated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes.Role of cytokines in the pathogenesis and suppression of thyroid autoimmunity.Blocking type TSH receptor antibodies.Graves' disease is associated with a defective expression of the immune regulatory molecule galectin-9 in antigen-presenting dendritic cells.Increased response to oxidative stress challenge in Graves' ophthalmopathy orbital fibroblasts.Meta-analysis of association between the +49A/G polymorphism of cytotoxic T-lymphocyte antigen-4 and thyroid associated ophthalmopathy.The evolving role of selenium in the treatment of graves' disease and ophthalmopathy.Graves' ophthalmopathy: a review of immunogenetics.Radiation therapy as part of the therapeutic regimen for extensive multilocular myxedema in a patient with exophthalmos, myxedema and osteoarthropathy syndrome: A case report.Thyroid-associated ophthalmopathy: a practical guide to classification, natural history and management.Selective IgA deficiency in autoimmune diseasesThyroid associated orbitopathy.
P2860
Q22306156-2DF9E697-9A9C-4C6C-98EA-9224CD00C8B2Q24202845-F4117EB8-7536-4474-AE54-729EC8E810FFQ24235160-20BC3705-8E91-4235-8CC3-45A2E4B7FB95Q24564205-10064A2B-76DD-450A-B1D1-B7F59904627DQ26771638-F949A4C3-F321-493A-8CAD-485B3871D401Q27691806-0A483C7B-D61A-434B-8221-3ED6B484CF79Q28255453-7E963BFB-3C54-407B-A4E2-09F77C7AD4F0Q28274196-852E127C-790B-4145-B84D-D5B6C9EFE0A0Q28730668-C7C9F310-152A-4B93-9AEF-B65302EFEF89Q30620542-2A7499F2-278D-484A-9C63-B7DA04C67749Q31047067-ED106088-14D1-4665-B727-7D989B5D03A7Q33306527-D0475F2E-DAF8-44E0-8C6C-9600D14CFD45Q33735061-A11C500C-F1DF-4F36-B92C-5E2F7C87EB98Q33789467-58827F69-D4B7-44CD-AAC1-88202DFE29ECQ33794950-14E115A8-C265-4959-A387-2B7587D47ABBQ33801404-EBC49CCB-8F6F-4EB9-B9BD-699AF371217DQ33802192-8054BEF0-9676-474F-A4A7-034197EB72C7Q33823673-9C3A4CFF-FEAF-412B-8239-F7F652867D24Q33847385-18149882-B110-4169-8440-CBDD7751AC74Q33890792-523C0DB1-9EC4-4A47-84B5-49CD6789B446Q34275875-348550C8-BF0C-4155-B491-3B4144C89CA5Q34493895-8ECFA50B-8594-411D-A338-726FD3B2731AQ34509459-EB45B3A8-3764-475A-9502-DB163697F77EQ34525298-73EDB49D-8B78-4414-83C2-6EC8EC284F25Q34548024-1B16EC56-321C-4FFB-BD68-B87EDC7B3E23Q35012933-70C42A9D-FAC9-4F0E-A4ED-105E571BCF50Q35203907-B38F3845-F7D8-444A-BD11-3A31892713E2Q35206790-DF9F6618-943A-4813-A6D7-D58897B506BBQ35222158-B896DE7D-FA94-45FE-B372-9B67CBEA945AQ35294492-4BDB3EAD-324B-404C-AE2F-EE90BCE6926FQ35309934-9A2A6F45-AB50-4515-A0CD-89D958642BB7Q35448029-87B65BFD-583C-48EC-8B19-E9177C366314Q35531750-6050AE81-E40A-4CC2-90E0-CFB68ED26106Q35547833-EEFD8857-6C17-4AAC-907E-39BDF437E073Q35725329-8EC776EA-24FD-4C55-815D-706C45C76940Q35731002-3EDE79BD-1108-4CD8-8807-569B1473D7BFQ35742184-391DACB9-2591-41C2-8B6E-D39331FA1EEBQ35866148-DA0E9712-03C8-452F-B936-F4F8259B3CD4Q35876782-863AADAD-CEB6-45D5-AAAA-B86C3EFCCD17Q35919247-CBDC8623-805F-4701-B23F-4E92052CB093
P2860
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
@ast
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
@en
type
label
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
@ast
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
@en
prefLabel
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
@ast
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy.
@en
P356
P1433
P1476
Current perspective on the pathogenesis of Graves' disease and ophthalmopathy
@en
P2093
Bellur S Prabhakar
Rebecca S Bahn
P304
P356
10.1210/ER.2002-0020
P577
2003-12-01T00:00:00Z